Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment

por So Yeon Oh, Soyeon Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo
Publicado 2021

Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients

por Ja Yoon Heo, Shin Hye Yoo, Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong-Wan Kim, Dae Seog Heo, Jong Seok Lee
Publicado 2021

Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers

por Chan-Young Ock, Jun-Eul Hwang, Bhumsuk Keam, Sang-Bae Kim, Jae-Jun Shim, Hee-Jin Jang, Sarang Park, Bo Hwa Sohn, Minse Cha, Jaffer A. Ajani, Scott Kopetz, Keun-Wook Lee, Tae Min Kim, Dae Seog Heo, Ju-Seog Lee
Publicado 2017

Human AQP5 plays a role in the progression of chronic myelogenous leukemia (CML).

por Young Kwang Chae, Sung Koo Kang, Myoung Sook Kim, Janghee Woo, Juna Lee, Steven Chang, Dong-Wook Kim, Myungshin Kim, Seonyang Park, Inho Kim, Bhumsuk Keam, Jiyoung Rhee, Nam Hee Koo, Gyeongsin Park, Soo-Hyun Kim, Se-Eun Jang, Il-Young Kweon, David Sidransky, Chulso Moon
Publicado 2008